欧美99一区二区三区,草日韩在线视频

Global Chemical Companies 2024 Financial report Market Trend Quarterly and annual 2024 financial highlights from major U.S. chemical and materials companies including Dow, DuPont, Ecolab, Celanese, Linde, Air Products, and more, with detailed revenue and profit comparisons.
Pfizer's Q1 2025 Financial report Market Trend Pfizer's Q1 2025 earnings report highlights strong adjusted EPS growth despite revenue decline. Key drivers include Comirnaty and Vyndaqel, with cost savings and R&D efficiency boosting performance.
Eli Lilly's Q1 2025 Financial report Market Trend Eli Lilly's Q1 2025 revenue surged 45% to $12.73B, driven by Mounjaro and Zepbound. U.S. GLP-1 prescription share hit 53.3%, surpassing Novo Nordisk. Key R&D and regulatory milestones achieved.
AstraZeneca's Q1 2025 Financial report Market Trend AstraZeneca's Q1 2025 revenue rose 10% to $13.59B, with strong growth in oncology and China contributing $1.8B. CEO highlights rich pipeline, U.S. expansion, and 2030 $80B revenue goal.
Novartis's Q1 2025 Financial report Market Trend Novartis reports strong Q1 2025 results with 12% sales growth, 27% core operating income increase, major FDA approvals, and raised full-year guidance amid robust innovation and strategic execution.
Sherwin-Williams's Q1 2025 Financial report Market Trend Sherwin-Williams reported Q1 2025 revenue of $5.31B, driven by strong growth in protective and marine coatings. Despite global headwinds, the company maintained stable profits and reaffirmed full-year guidance.
WuXi AppTec's Q1 2025 Financial report Market Trend WuXi AppTec reports strong Q1 2025 results with net profit up 89% YoY and orders reaching RMB 52.33 billion. Its CRDMO model drives growth across chemistry, testing, and biology services, showing resilience amid global challenges.
Gilead's Q1 2025 Financial report Financial statements Gilead's Q1 2025 report shows stable revenue, strong HIV and hepatitis sales growth, major R&D progress, and reaffirmed full-year guidance, driven by products like Biktarvy, Trodelvy, and lenacapavir.
AbbVie's Q1 2025 Financial report Financial statements AbbVie’s Q1 2025 report reveals soaring sales of Skyrizi and Rinvoq amid Humira’s decline. Explore how innovation, competition, and strategic shifts are reshaping AbbVie’s future in immunology and beyond.
The Cost of Attacking the Pharmaceutical Industry Trump Trump's policies during his second term have rocked the U.S. scientific community, slashing NIH funding, threatening pharmaceutical innovation, and reshaping the global research landscape amid rising concerns about America's future in science.

< Pre 1...19 20 212223 24 25...26 Next >

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水